Monash Medical Centre

Quick facts

Marketed products

• Methylphenidate Hydrochloride 18 MG

Phase 3 pipeline

• Anakinra (Kineret®) · Immunology
  Anakinra blocks interleukin-1 (IL-1) receptor signaling to reduce inflammatory cytokine activity.

Phase 2 pipeline

• Effects of anticholinergic medication

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Monash Medical Centre portfolio CI brief
• Monash Medical Centre pipeline updates RSS